Literature DB >> 14633540

The effect of cerebral monitoring on recovery after general anesthesia: a comparison of the auditory evoked potential and bispectral index devices with standard clinical practice.

Alejandro Recart1, Irina Gasanova, Paul F White, Tojo Thomas, Babatunde Ogunnaike, Mohammed Hamza, Agnes Wang.   

Abstract

UNLABELLED: The use of cerebral monitoring may improve the ability of anesthesiologists to titrate anesthetic drugs. However, there is controversy regarding the impact of the alleged anesthetic-sparing effects of cerebral monitoring on the recovery process and patient outcome. We designed this prospective double-blinded, sham-controlled study to evaluate the impact of intraoperative monitoring with the electroencephalogram bispectral index (BIS) or auditory evoked potential (AEP) device on the usage of desflurane and the time to discharge from the recovery room, as well as on patient satisfaction with their anesthetic experience and recovery. Ninety healthy patients undergoing laparoscopic general surgery procedures using a standardized anesthetic technique were randomly assigned to one of three monitoring groups: standard clinical practice (control), BIS-guided, or AEP-guided. Both the BIS and AEP monitors were connected to all patients before induction of general anesthesia. In the control group, the anesthesiologists were not permitted to observe the BIS or AEP index values during the intraoperative period. In the BIS-guided group, the volatile anesthetic was titrated to maintain a BIS value in the range of 45-55. In the AEP-guided group, the targeted AEP index range was 15-20. The BIS and AEP indices, as well as end-tidal desflurane concentration, were recorded at 3-5 min intervals. Recovery times to awakening, tracheal extubation, fast-track score >or=12, and postanesthesia care unit (PACU) discharge criteria were recorded at 1-10 min intervals. In addition, patient satisfaction with anesthesia and quality of recovery were evaluated on 100- and 18-point scales, respectively, at 24 h after surgery. The AEP- and BIS-guided groups were administered significantly smaller average end-tidal desflurane concentrations than the control group (3.8 +/- 0.9 and 3.9 +/- 0.6 versus 4.7 +/- 1.7, respectively) (P < 0.01). Although the emergence times to eye opening, tracheal extubation, and obeying commands were consistently shorter in the AEP and BIS groups (6 +/- 4 and 6 +/- 5 versus 8 +/- 8 min; 6 +/- 5 and 6 +/- 4 versus 11 +/- 10 min; and 8 +/- 4 and 7 +/- 4 versus 12 +/- 9 min, respectively), only the extubation times were significantly different from the control group (P < 0.05). More importantly, the length of the PACU stay was significantly shorter in both the AEP- and BIS-guided groups (79 +/- 43 and 80 +/- 47 versus 108 +/- 58 min, respectively) (P < 0.05). The patients' quality of recovery was also significantly higher in the two monitored groups (15 +/- 2 versus 13 +/- 3 in the control group, P < 0.05). We concluded that cerebral monitoring with either the BIS or AEP devices reduced the maintenance anesthetic (desflurane) requirement, resulting in a shorter length of stay in the PACU and improved quality of recovery after laparoscopic surgery. However, there were no significant outcome differences between the two cerebral monitored groups. IMPLICATIONS: Compared with standard monitoring practices, use of an auditory evoked potential or bispectral index monitor to titrate the volatile anesthetic led to a significant reduction in the anesthetic requirement. The anesthetic-sparing effect of cerebral monitoring resulted in a shorter postanesthesia care unit stay and improved quality of recovery from the patient's perspective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633540     DOI: 10.1213/01.ane.0000087041.63034.8c

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  34 in total

1.  Titration of sevoflurane in elderly patients: blinded, randomized clinical trial, in non-cardiac surgery after beta-adrenergic blockade.

Authors:  David R Drover; Clifford Schmiesing; Anthea F Buchin; H Rick Ortega; Jonathan W Tanner; Joshua H Atkins; Alex Macario
Journal:  J Clin Monit Comput       Date:  2011-08-10       Impact factor: 2.502

Review 2.  Bispectral Index Versus Standard Monitoring in Sedation for Endoscopic Procedures: A Systematic Review and Meta-Analysis.

Authors:  Se Woo Park; Hyuk Lee; Hongyup Ahn
Journal:  Dig Dis Sci       Date:  2015-11-03       Impact factor: 3.199

Review 3.  [Measurement of the depth of anaesthesia].

Authors:  G N Schmidt; J Müller; P Bischoff
Journal:  Anaesthesist       Date:  2008-01       Impact factor: 1.041

4.  Awareness during anesthesia: how sure can we be that the patient is sleeping indeed?

Authors:  G Kotsovolis; G Komninos
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

Review 5.  Bispectral index for improving anaesthetic delivery and postoperative recovery.

Authors:  Yodying Punjasawadwong; Aram Phongchiewboon; Nutchanart Bunchungmongkol
Journal:  Cochrane Database Syst Rev       Date:  2014-06-17

6.  Awareness during anaesthesia.

Authors:  K Sandhu; Hh Dash
Journal:  Indian J Anaesth       Date:  2009-04

7.  Effect of remifentanil on consumption of sevoflurane in entropy monitored general anesthesia.

Authors:  Hyung Tae Kim; Hyeon Eon Heo; Young Eun Kwon; Myeong Jong Lee
Journal:  Korean J Anesthesiol       Date:  2010-10-21

8.  Bispectral index monitor: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2004-06-01

9.  The Effects of Bispectral Index and Neuromuscular Blockade Monitoring on the Depth of Anaesthesia and Recovery in Cardiac Patients Under Desflurane Anaesthesia.

Authors:  Ayşe Payas; Kenan Kaygusuz; Cevdet Düger; Ahmet Cemil İsbir; İclal Özdemir Kol; Sinan Gürsoy; Caner Mimaroğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2013-06-14

10.  Dexmedetomidine for patients undergoing diagnostic cardiac procedures: a noninferiority study.

Authors:  Nina Deutsch; Julia C Finkel; Karen Gold; Yao I Cheng; Michael C Slack; Joshua Kanter; Zenaide M N Quezado
Journal:  Pediatr Cardiol       Date:  2012-11-04       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.